Final answer:
Antiretroviral therapy used in treating HIV may lead to the development of Type 2 diabetes. Some antiretroviral drugs can alter glucose metabolism, raising the risk of insulin resistance.
Step-by-step explanation:
The antiretroviral therapy (ART) used for treating HIV infection can have several side effects, one of which is the development of Type 2 diabetes. This development occurs because some antiretroviral medications can lead to changes in glucose metabolism, which increases the risk of developing insulin resistance—a precursor to Type 2 diabetes. In contrast, conditions such as Hypoglycemia, Pruritus, and Blount's disease are not commonly associated with the use of antiretroviral therapy.
Type 2 diabetes is now often classified as an autoimmune disease by many scientists due to its nature of beginning as chronic inflammation. Antiretroviral drugs, especially protease inhibitors and nucleoside reverse transcriptase inhibitors, have been implicated in the dysregulation of glucose homeostasis. It's important for patients to be monitored for signs of new-onset diabetes or worsening diabetes control.